Precision BioSciences
DTIL
DTIL
109 hedge funds and large institutions have $159M invested in Precision BioSciences in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 28 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 30
30% less call options, than puts
Call options by funds: $347K | Put options by funds: $498K
59% less capital invested
Capital invested by funds: $387M → $159M (-$228M)
Holders
109
Holding in Top 10
3
Calls
$347K
Puts
$498K
Top Buyers
| 1 | +$3.38M | |
| 2 | +$2.28M | |
| 3 | +$989K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$882K |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$846K |
Top Sellers
| 1 | -$8.97M | |
| 2 | -$2.78M | |
| 3 | -$2.21M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.09M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.75M |